This article was written by Follow The Investment Doctor is a financial writer, highlighting European small-caps with a 5-7 year investment horizon. He strongly...
This article was written by Follow Victor Dergunov is an independent investor and author with 20 years experience. He preaches diversification and shares investment...
What’s the best-performing sector in 2023? You might say something tech-related. While that is true among large-cap US equities, small and mid-sized companies within...
At a Glance In light of Lyra Therapeutics’ (NASDAQ:LYRA) recent financial and clinical data, investors face a complex investment landscape. On the clinical side,...
After Lucid Group (NASDAQ:LCID) disappointed multiple times with its delivery achievements in FY 2023 and dropped its EV prices by a considerable percentage, the...
The potential Exxon Mobil (XOM) deal to acquire Pioneer Natural Resources (PXD) should make Devon Energy (NYSE:DVN) even more appealing. The independent energy company...
Big Dividends PLUS, Blue Harbinger The BlackRock Health Sciences Term Trust (NYSE:BMEZ) is a closed-end fund (“CEF”) that recently announced a distribution cut, and...